Certified Advisory Corp’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Certified Advisory Corp’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-669	Closed	-$91K	–	749
2021 Q1	$91K	Buy	+669	New	+$100K	0.02%	269
2020 Q2	$24K	Hold	215	–	–	0.01%	411
2020 Q1	$17K	Hold	215	–	–	0.01%	450
2019 Q4	$20K	Sell	215 -1,145	-84%	-$99K	0.01%	485
2019 Q3	$104K	Buy	1,360 +190	+16%	+$15.8K	0.04%	234
2019 Q2	$103K	Sell	1,170 -250	-18%	-$21.3K	0.04%	230
2019 Q1	$129K	Sell	1,420 -25	-2%	-$2.13K	0.05%	193
2018 Q4	$104K	Sell	1,445 -305	-17%	-$24.6K	0.05%	195
2018 Q3	$168K	Buy	1,750 +440	+34%	+$42.7K	0.08%	161
2018 Q2	$125K	Buy	1,310 +306	+30%	+$28.1K	0.07%	178
2018 Q1	$88K	Sell	1,004 -16	-2%	-$1.46K	0.05%	206
2017 Q4	$86K	Buy	+1,020	New	+$85.4K	0.06%	173

Other funds holding XBI

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Certified Advisory Corp's XBI Position: Q2 2021 in Review

Certified Advisory Corp sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2021, closing a stake of 669 shares — an estimated $91K sold.

Certified Advisory Corp first reported a position in XBI in Q4 2017 and held it in 12 quarters. The position peaked at $168K in Q3 2018. 663 funds tracked by Wall St. Rank hold XBI as of Q2 2021.

Certified Advisory Corp reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2021 after selling out during the quarter.
Certified Advisory Corp sold 669 State Street SPDR S&P Biotech ETF shares in Q2 2021, an estimated $91K.
Certified Advisory Corp first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and held it in 12 quarters.
Certified Advisory Corp's State Street SPDR S&P Biotech ETF position peaked at $168K in Q3 2018.
663 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2021.

Based on Certified Advisory Corp's 13F filing for Q2 2021, filed 16 Aug 2021.